DB17997ApprovedWithdrawn
Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (propiolactone inactivated) is a component of an inactivated influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that helps to protect against infection from influenza viruses.
- First approval
- United States, 2023
Resolves to
Compound
What you can answer from here — as of August 04, 2026
Which companies are running trials of Influenza A virus A/Victoria/4897/2022 IVR-238 (H1N1) Antigen (propiolactone inactivated), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account